Renaissance Capital logo

ShangPharma Corporation

, NYSE: SHP

Second-largest Chinese pharmaceutical/biotechnology R&D outsourcing firm.

Industry: Health Care

First Day Return: -15.0%

Second-largest Chinese pharmaceutical/biotechnology R&D outsourcing firm.
IPO Data
IPO Date 10/18/2010
Offer Price IPO Intelligence Only
Price Range IPO Intelligence Only
Offer Shares (mm) IPO Intelligence Only
Deal Size ($mm) $87
Lock-Up Date IPO Intelligence Only
Street Research IPO Intelligence Only
Underwriters
IPO Intelligence Only
Company Data
Headquarters Shanghai, China
Founded 2002
Employees at IPO n/a
Website www.shangpharma.com

ShangPharma Corporation (SHP) Performance